Edonerpic Uses, Dosage, Side Effects and more
Edonerpic is a neurotrophic agent intended for the treatment of Alzheimer's disease which is under phase I clinical trial.
| Attribute | Details |
|---|---|
| Trade Name | Edonerpic |
| Generic | Edonerpic |
| Edonerpic Other Names | Edonerpic |
| Type | |
| Formula | C16H21NO2S |
| Weight | Average: 291.41 Monoisotopic: 291.129300094 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in alzheimer's disease.
How Edonerpic works
T-817MA has neuroprotective properties. Toyama Chemical has demonstrated that T-817MA prevents neurodegeneration induced by Amyloid-b protein. Accumulation of Amyloid-b protein is considered to be central to the pathogenesis of Alzheimer's disease. The neuroprotective properties of T-817MA were also observed in a mutant tau induced Alzheimer's disease model. Besides these neuroprotective properties, T-817MA also promotes neurite outgrowth.
